Reaction: Lepirudin to 1 product

Reaction
Lepirudin
DB00001
    M1 (1-64)
    DBMET03462
    Reaction type
    hydrolysis
    Direction
    Major circulating metabolite?
    No
    Spontaneous?
    No
    Activity
    active
    References
    1. FDA Clinical Pharmacology and Biopharmaceutics Review: Refludan (lepirudin) lyophilized powder for intravenous injection [Link]
    Comments
    Lepirudin is metabolized by the sequential cleavage of terminal amino acids.[L41544]
    Enzymes
    Not Available